Answer
Daratumumab (Darzalex) infusion is contraindicated in patients with hypersensitivity to daratumumab or any excipient listed in section 6.1 of its product information.
Sources for this answer
- DARZALEX 20 mg/mL concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 36Document updated
Sources checked